Evaluation of two commercial omalizumab/free IgE immunoassays: implications of use during therapy

Author： Baker Dana L.   Peng Kun   Cheu Melissa   Fischer Saloumeh Kadkhodayan  

Publisher： Informa Healthcare

ISSN： 1473-4877

Source： Current Medical Research and Opinion, Vol.30, Iss.5, 2014-05, pp. : 913-922

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Utility of serum periostin and free IgE levels in evaluating responsiveness to omalizumab in patients with severe asthma

By  

ALLERGY, Vol. 71, Iss. 10, 2016-10 ,pp. : 1472-1479

John Wiley & Sons Inc

Access to resources Recommend Favorite

Influence of Omalizumab on Allergen-Specific IgE in Patients with Adult Asthma

By  

International Archives of Allergy and Immunology, Vol. 168, Iss. 3, 2015-0 ,pp. : 165-172

Karger

Access to resources Recommend Favorite

Omalizumab's Impact on Total and Allergen-Specific IgE Levels: A Polyclonal Story

By  

International Archives of Allergy and Immunology, Vol. 169, Iss. 2, 2016-04 ,pp. : 69-70

Karger

Access to resources Recommend Favorite

IgE Inhibition as a Therapy for Allergic Disease

By  

International Archives of Allergy and Immunology, Vol. 118, Iss. 2-4, 1999-04 ,pp. : 112-115

Karger

Access to resources Recommend Favorite

Anti-IgE Therapy with Omalizumab Decreases Endothelin-1 in Exhaled Breath Condensate of Patients with Severe Persistent Allergic Asthma

By  

Respiration, Vol. 80, Iss. 6, 2010-06 ,pp. : 534-542

Karger

Access to resources Recommend Favorite